Nadolol (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Nadolol drug offered from Mylan Pharmaceuticals Inc.. This Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
NON-PROPRIETARY NAME: | nadolol |
SUBSTANCE NAME: | NADOLOL |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 1993-10-31 |
END MARKETING DATE: | 0000-00-00 |
Nadolol HUMAN PRESCRIPTION DRUG Details:
Item Description | Nadolol from Mylan Pharmaceuticals Inc. |
LABELER NAME: | Mylan Pharmaceuticals Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 80(mg/1) |
START MARKETING DATE: | 1993-10-31 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 0378-1132_af74832c-d5c4-4c96-ad1c-5f6c228f09ce |
PRODUCT NDC: | 0378-1132 |
APPLICATION NUMBER: | ANDA074172 |
Other NADOLOL Pharmaceutical Manufacturers / Labelers: